Back QuickSTAT Opens New Facility in Germany to Serve the Healthcare, Pharma & Biotech Industries
QuickSTAT has opened a new customer service and operational facility in Frankfurt, Germany to support the country’s growth within the healthcare, pharma and biotech industries, as well as the expected increase of new cell and gene therapies. QuickSTAT’s new facility is strategically located to not only serve clients in Germany, but also throughout Europe, providing the continent with customized logistics and priority transportation solutions.
Germany is a key market for the pharma and biotech industry—it is the third largest in the world and the largest in Europe. A driver for the industry, Germany leads other European countries in terms of API manufacturing, competitiveness, innovation, finished product manufacturing, and growth potential for pharmaceutical investment.
QuickSTAT is an expert in managing global clinical trial logistics for all phases of research and drug development through to commercialization. The company specializes in time- and temperature-sensitive shipping of clinical research samples, cell and gene therapies, investigational drugs, and clinical trial supplies, helping to bring new drugs and medical protocols to market. “We are pleased to provide seamless end-to-end logistics and transportation solutions for our customers in Germany.
Our investment in this new state-of-the-art facility demonstrates our commitment to the healthcare, pharmaceutical and biotech community worldwide,” said Cyril Leger, Executive Vice President of QuickSTAT.